Delivery Order SPE2DR25D2012-SPE2DR26F1BKB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,181.21. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count unit) with a ceiling value of $1,216.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,079.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,651.64. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,009.16. This competitive, firm fixed-price delivery order is scheduled for completion by May 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) with a ceiling value of $8,109.38. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $4,143.96 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count). This competitively awarded, firm fixed-price contract was issued on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,672.67 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed-price contract with an ultimate completion date of October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,931.32. This is a firm fixed price delivery order without set-aside designation, demonstrating competitive award of this pharmaceutical product. The order is scheduled for completion by June 30, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BKBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count) with a ceiling value of $1,257.88. This competitively awarded, firm fixed-price delivery order is set to be completed by November 18, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds an extensive portfolio of competitively awarded federal contracts with the Defense Logistics Agency covering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This specific delivery order for Lisdexamfetamine—a medication commonly used in the treatment of attention deficit hyperactivity disorder—reflects the company's ongoing role as a key supplier of neurological and behavioral health pharmaceuticals to the Department of Defense and affiliated healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/17/25 |